Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C

Authors

• M.D. Cappellini
• M. Elalfy
• A. El-Beshlawy
• A. Kattamis
• L.L. Chan
• C. Li
• K.H. Lin
• G. Quarta
• P. Sutcharitchan
• A. Taher
• D. Habr
• B. Roubert
• J. Porter

Document Type

Article

Publication Date

1-1-2010

Publication Title

Haematologica-The Hematology Journal

Recommended Citation

Cappellini, M.D.; Elalfy, M.; El-Beshlawy, A.; Kattamis, A.; Chan, L.L.; Li, C.; Lin, K.H.; Quarta, G.; Sutcharitchan, P.; Taher, A.; Habr, D.; Roubert, B.; and Porter, J., "Efficacy of deferasirox in patients with thalassaemia major is not affected by a history of hepatitis B OR C" (2010). Research Publications (2006 to 2010). 3441.
https://knova.um.edu.my/research_publications_2006_2010/3441

Volume

95

Issue

2

Additional Information

15th Annual Meeting of the European-Hematology-Association, Barcelona, SPAIN, JUN 10-13, 2010